Active Post-Marketing Safety Surveillance of Innovative Drugs: Practice and Challenges of Real-World Studies

doi:10.3969/j.issn.1673-5390.2026.09.007

LI Cheng-yan

China Food Drug Administration ›› 2026, Vol. 0 ›› Issue (9) : 70-79.

PDF(3731 KB)

China Food Drug Administration ›› 2026, Vol. 0 ›› Issue (9) : 70-79. DOI: 10.3969/j.issn.1673-5390.2026.09.007

Research of Regulatory Science

Active Post-Marketing Safety Surveillance of Innovative Drugs: Practice and Challenges of Real-World Studies

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 0(9): 70-79 https://doi.org/10.3969/j.issn.1673-5390.2026.09.007

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(3731 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export